Pharmacogenetics of Antidepressants: Is There a Magic Bullet for Treating Depression?_

:::

詳目顯示

第 1 筆 / 總合 1 筆

/1頁

來源文獻資料
摘要
外文摘要
引文資料

題名：	Pharmacogenetics of Antidepressants: Is There a Magic Bullet for Treating Depression?
書刊名：	Taiwanese Journal of Psychiatry
作者：	李敏秀
作者(外文)：	Lee, Min-soo
出版日期：	2016
卷期：	30:2
頁次：	頁79-90+a6
主題關鍵詞：	抗憂鬱劑；單胺；藥物基因學；全基因體關聯性研究；Antidepressants；Monoamines；Pharmacogenetics；Genome-wide association studies；GWAS
原始連結：	連回原系統網址
相關次數：	被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0) 排除自我引用:1 共同引用:0 點閱:10

憂鬱症是現今社會最常見的精神疾患之一。已有許多精神醫學領域的研究者投身於憂鬱症病因的研究，但臨床上對於抗憂鬱劑治療反應的個體差異問題仍持續存在。為了更順利地進入本文主題，筆者將會先介紹單胺假說、血清素在造成臨床憂鬱症的角色、以及抗憂鬱劑的問世（簡短描述三環抗憂鬱劑、選擇性血清素回收抑制劑，及其他新型抗憂鬱劑），接下來再介紹藥物基因學的概念與候選基因(candidate genes)。筆者認為，基因因素被視為對藥物反應有獨立的影響，並舉四個基因研究為例：血清素轉運體 (5-HTT/SLC6A4) 與血清素受體2A (HTR2A)、G 蛋白β3 次單元 (GNB3)、腦源性神經滋養因子 (BDNF)、及色胺酸水解酶(TPH)。值得注意的是，其中有些候選基因研究的結果是不一致的。2009 年起，全基因體關聯性研究 (Genome-wide Association Studies, GWAS) 提供了更進一步的基礎以瞭解抗憂鬱劑及憂鬱症治療的藥物基因學機轉，但更多的研究及技術的發展仍是需要的。

以文找文

Depression is one of the most common mental disorders nowadays. Many researchers in psychiatry have investigated the cause of depression. Unfortunately, the problem of individual differences in response to antidepressant treatment still lingers in the clinical fi eld. For setting up the stage for the main topics in the later part of this overview, I start introducing the topics of monoamine hypothesis, the rôle of serotonin in causing clinical depression, as well as advents of antidepressants (briefl y describing tricyclic antidepressants, the arrival of selective serotoninreuptake inhibitor, and novel antidepressants). Then, I introduce the concept of pharmacogenetics, the candidate genes. Afterwards, I consider that genetic factors are recognized to have an independent effect on drug responses. To demonstrate, I highlight fi ve gene studies-serotonin transporter (5-HTT/SLC6A4), serotonin receptor 2A (HTR2A), G-protein β3 subunit (GNB3), brain-derived neurotrophic factor (BDNF), and tryptophan hydroxylase (TPH). But some of candidate gene studies have been conducted, but results were not consistent. Since 2009, Genomewide Association Studies (GWAS) has provided further grounds for understanding the pharmacogenetic mechanisms of antidepressants and depression treatment. Further research and technological development are still needed.

以文找文

期刊論文
1.	Verhagen, M.、van der Meij, A.、van Deurzen, P. A.、Janzing, J. G. E.、Arias-Vasquez, A.、Buitelaar, J. K.、Franke, B.(2010)。Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity。Mol Psychiatry，15(3)，260-271。
2.	Hasin, D. S.、Goodwin, R. D.、Stinson, F. S.、Grant, B. F.(2005)。Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions。Archives of General Psychiatry，62，1097-1106。
3.	Kapur, S.、Remington, G.(1996)。Serotonin-dopamine interaction and its relevance to schizophrenia。Am J Psychiatry，153，466-476。
4.	Carlsson, A.、Lindqvist, M.、Magnusson, T.(19571130)。3, 4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as reserpine antagonists。Nature，180。
5.	Kessler, R. C.、Berglund, P.、Demler, O.(2003)。The epide miology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)。JAMA，289，3095-3105。
6.	Insel, T. R.、Charney, D. S.(2003)。Research on major depression: strategies and priorities。JAMA，289，3167-3168。
7.	Huapaya, L.、Ananth, J.(1980)。Is there a relation between de pression and hypertension?。Rev Neuropsiquiatr，43，97-105。
8.	Freis, E. D.(1954)。Mental depression in hypertensive patients treated for long periods with large doses of reserpine。N Engl J Med，251，1006-1008。
9.	Oquendo, M. A.、Ellis, S. P.、Greenwald, S.、Malone, K. M.、Weissman, M. M.、Mann, J. J.(2001)。Ethnic and sex differences in suicide rates relative to major depression in the United States。Am J Psychiatry，158，1652-1658。
10.	Nemeroff, C. B.(1998)。The neurobiology of depression。Sci Am，278，42-49。
11.	Shore, P. A.、Silver, S. L.、Brodie, B. B.(1955)。Interaction of reser pine, serotonin, and lysergic acid diethylamide in brain。Science，122，284-285。
12.	López-Muñoz, F.、Álamo, C.、Juckel, G.、Assion, H. J.(2007)。Half a century of antidepressant drugs: on the clinical in troduction of monoamine oxidase inhibitors, tricy clics, and tetracyclics. part I: monoamine oxidase inhibitors。J Clin Psychopharmacol，27，555-559。
13.	López-Muñoz, F.、Shen, W. W.、Álamo, C.、Cacabelos, R.(2014)。Serendipitous discovery of first two antidepressants。Taiwanese Journal of Psychiatry，28，67-70。
14.	Boadle-Biber, M. C.(1993)。Regulation of serotonin synthesis。Prog Biophysic Mol Biol，60，1-15。
15.	Berger, M.、Gray, J. A.、Roth, B. L.(2009)。The expanded biology of serotonin。Ann Rev Med，60，355-366。
16.	Sulser, F.(1987)。Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders。J Clin Psychiatry，48，12-18。
17.	Bymaster, F. P.、Zhang, W.、Carter, P. A.(2002)。Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex。Psychopharmacology (Berl)，160(4)，353-361。
18.	Wong, D. T.、Bymaster, F. P.、Engleman, E. A.(1995)。Prozac (fluoxetine, Lilly 110140), the first selective serotonin up take inhibitor and an antidepressant drug: twenty years since its first publication。Life Sci，57，411-441。
19.	Tollefson, G. D.、Rampey, A. H.、Potvin, J. H.(1994)。A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder。Arch Gen Psychiatry，51，559-567。
20.	Schneier, F. R.、Liebowitz, M. R.、Davies, S. O.(1990)。Fluoxetine in panic disorder。J Clin Psychopharmacol，10，119-121。
21.	Joffe, R. T.、Sokolov, S. T.(2000)。Thyroid hormone treatment of primary unipolar depression: a review。Int J Neuropsychopharmacol，3，143-147。
22.	Philip, N. S.、Carpenter, L. L.、Tyrka, A. R.、Price, L. H.(2010)。Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era。Exp Opin Pharmacother，11，709-722。
23.	Olié, J. P.、Kasper, S.(2007)。Efficacy of agomelatine, a MT 1/ MT 2 receptor agonist with 5-HT 2C antagonistic properties, in major depressive disorder。Int J Neuropsychopharmacol，10(5)，661-673。
24.	O'Reilly, R. L.、Bogue, L.、Singh, S. M.(1994)。Pharmacogenetic response to antidepressants in a multicase family with affective disorder。Biol Psychiatry，36，467-471。
25.	Pare, C.、Rees, L.、Sainsbury, M.(1962)。Differentiation of two genetically specific types of depression by the re sponse to anti-depressants。Lancet，280，1340-1343。
26.	Franchini, L.、Serretti, A.、Gasperini, M.、Smeraldi, E.(1998)。Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees。J Psychiatr Res，32，255-259。
27.	Fabbri, C.、Serretti, A.(2015)。Pharmacogenetics of major de pressive disorder: top genes and pathways toward clinical applications。Curr Psychiatry Rep，17，1-11。
28.	Serretti, A.、Kato, M.、De Ronchi, D.、Kinoshita, T.(2007)。Meta analysis of serotonin transporter gene promoter poly morphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients。Mol Psychiatry，12，247-257。
29.	Porcelli, S.、Fabbri, C.、Serretti, A.(2012)。Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy。Eur Neuropsychopharmacol，22，239-258。
30.	McMahon, F. J.、Buervenich, S.、Charney, D.(2006)。Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment。Am J Hum Genet，78，804-814。
31.	Peters, E. J.、Slager, S. L.、Jenkins, G. D.(2009)。Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response。Pharmacogenet Genom，19，1-10。
32.	Kishi, T.、Yoshimura, R.、Kitajima, T.(2010)。HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort。Neuromol Med，12，237-242。
33.	Fabbri, C.、Marsano, A.、Albani, D.(2014)。PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway。Pharmacogenom J，14，463-472。
34.	Fabbri, C.、Di Girolamo, G.、Serretti, A.(2013)。Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research。Am J Med Genet Part B Neuropsychiatr Genet，162，487-520。
35.	Perlis, R. H.、Fijal, B.、Adams, D. H.、Sutton, V. K.、Trivedi, M. H.、Houston, J. P.(2009)。Variation in catechol-O-methyl transferase is associated with duloxetine response in a clinical trial for major depressive disorder。Biol Psychiatry，65，785-791。
36.	Horstmann, S.、Lucae, S.、Menke, A.(2010)。Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment。Neuropsychopharmacology，35，727-740。
37.	Hu, Q.、Zhang, S.-Y.、Liu, F.(2015)。Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis。J Affect Disord，172，103-109。
38.	Zill, P.、Baghai, T. C.、Zwanzger, P.(2000)。Evidence for an association between a G-protein β3-gene variant with depression and response to antidepressant treatment。Neuroreport，11，1893-1897。
39.	Lee, H. J.、Cha, J.、Ham, B. J.(2004)。Association between a G-protein β3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders。Pharmacogenom J，4，29-33。
40.	Keers, R.、Bonvicini, C.、Scassellati, C.(2011)。Variation in GNB3 predicts response and adverse reactions to antidepressants。J Psychopharmacol，25，867-874。
41.	Joyce, P. R.、Mulder, R. T.、Luty, S. E.(2003)。Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortripty line。Int J Neuropsychopharmacol，6，339-346。
42.	Wilkie, M. J.、Smith, D.、Reid, I. C.(2007)。A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression。Pharmacogenet Genom，17，207-215。
43.	Lin, E.、Chen, P. S.、Chang, H. H.(2009)。Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder。Prog Neuro-Psychopharmacol Biol Psychiatry，33，1167-1172。
44.	Hong, C.、Chen, T.、Yu, Y. W.、Tsai, S.(2006)。Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder。Pharmacogenomics J，6，27-33。
45.	Kang, R. H.、Hahn, S. W.、Choi, M. J.、Lee, M. S.(2007)。Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression。Neuropsychobiology，56，1-5。
46.	Kato, M.、Wakeno, M.、Okugawa, G.(2008)。Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients。Prog Neuro-Psychopharmacol Biol Psychiatry，32，1041-1044。
47.	Fernandes, B.、Berk, M.、Turck, C.、Steiner, J.、Goncalves, C.(2014)。Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta analysis。Mol Psychiatry，19，750-751。
48.	Polyakova, M.、Stuke, K.、Schuemberg, K.、Mueller, K.、Schoenknecht, P.、Schroeter, M. L.(2015)。BDNF as a biomarker for successful treatment of mood disorders: a systematic and quantitative meta-analysis。J Affect Disord，174，432-440。
49.	Yan, T.、Wang, L.、Kuang, W.(2014)。Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis。Asia Pac Psychiatry，6，241-251。
50.	Chang, H. S.、Lee, H. Y.、Ham, B. J.(2012)。Association be tween brain-derived neurotrophic factor V66M and treatment responses to escitalopram in patients with major depressive disorder。Asia Pac Psychiatry，4，241-249。
51.	Choi, M. J.、Kang, R. H.、Lim, S. W.、Oh, K. S.、Lee, M. S.(2006)。Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder。Brain Res，1118，176-182。
52.	Kang, R.、Chang, H.、Wong, M.(2010)。Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression。J Psychopharmacol，24，1755-1763。
53.	Chen, L.、Lawlor, D. A.、Lewis, S. J.(2008)。Genetic asso ciation study of BDNF in depression: Finding from two cohort studies and a meta-analysis。Am J Med Genet Part B Neuropsychiatr Genet，147，814-821。
54.	Cooper, J. R.、Melcer, I.(1961)。The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin。J Pharmacol Eexper Ther，132，265-268。
55.	Bellivier, F.、Leboyer, M.、Courtet, P.(1998)。Association between the tryptophan hydroxylase gene and manic depressive illness。Arch Gen Psychiatry，55，33-37。
56.	Serretti, A.、Zanardi, R.、Rossini, D.、Cusin, C.、Lilli, R.、Smeraldi, E.(2001)。Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity。Mol Psychiatry，6，586-592。
57.	Ham, B. J.、Lee, B. C.、Paik, J. W.(2007)。Association be tween the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population。Prog Neuro Psychopharmacol Biol Psychiatry，31，104-107。
58.	Arias, B.、Fabbri, C.、Gressier, F.(2012)。TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression。Neuropsychobiology，67，41-47。
59.	Gizatullin, R.、Zaboli, G.、Jonsson, E. G.、Asberg, M.、Leopardi, R.(2006)。Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression。Biol Psychiatry，59，295-300。
60.	Yoshida, K.、Naito, S.、Takahashi, H.(2002)。Monoamine oxidase: a gene polymorphism, tryptophan hydroxy lase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder。Prog Neuro-Psychopharmacol Biol Psychiatry，26，1279-1283。
61.	Ham, B. J.、Lee, M. S.、Lee, H. J.(2005)。No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population。Psychiatr Genet，15，299-301。
62.	Kato, M.、Wakeno, M.、Okugawa, G.(2007)。No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression。Neuropsychobiology，56，167-171。
63.	Wang, H. C.、Yeh, T. L.、Chang, H. H.(2011)。TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients。Psychopharmacology，213，773-779。
64.	Walther, D. J.、Bader, M.(2003)。A unique central tryptophan hydroxylase isoform。Biochem Pharmacol，66，1673-1680。
65.	Zill, P.、Baghai, T.、Zwanzger, P.(2004)。SNP and haplotype analysis of a novel tryptophan hydroxylase iso form (TPH2) gene provide evidence for association with major depression。Mol Psychiatry，9，1030-1036。
66.	Van Den Bogaert, A.、Sleegers, K.、De Zutter, S.(2006)。Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population。Arch Gen Psychiatry，63，1103-1110。
67.	Gao, J.、Pan, Z.、Jiao, Z.(2012)。TPH2 gene polymorphisms and major depression-a meta-analysis。PloS One，7，e36721。
68.	Gizatullin, R.、Zaboli, G.、Jönsson, E. G.、Åsberg, M.、Leopardi, R.(2008)。The tryptophan hydroxylase (TPH) 2 gene unlike TPH-1 exhibits no association with stress-induced depression。J Affect Disord，107，175-179。
69.	Yin, L.、Zhang, Y.、Zhang, X.、Yu, T.、He, G.、Sun, X.(2015)。TPH, SLC6A2, SLC6A3, DRD2 and DRD4 polymorphisms and neuroendocrine factors predict SSRIs treatment outcome in the Chinese population with major depression。Pharmacopsychiatry，48，95-103。
70.	Uher, R.、Perroud, N.、Ng, M. Y.(2010)。Genome-wide pharmacogenetics of antidepressant response in the GENDEP project。Am J Psychiatry，167，555-564。
71.	Garriock, H. A.、Kraft, J. B.、Shyn, S. I.(2010)。A genomewide association study of citalopram response in major depressive disorder。Biol Psychiatry，67，133-138。
72.	Ising, M.、Lucae, S.、Binder, E. B.(2009)。A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression。Arch Gen Psychiatry，66，966-975。
73.	Anguelova, M.、Benkelfat, C.、Turecki, G.(2003)。A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders。Mol Psychiatry，8，574-591。
74.	McGonagle, Katherine A.、Kendler, Kenneth S.、Wittchen, Hans-Ulrich、Zhao, Shanyang、Eshleman, Suzann、Hughes, Michael、Nelson, Christopher B.、Kessler, Ronald C.(1994)。Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey。Archives of General Psychiatry，51(1)，8-19。
75.	Tsai, S. J.、Cheng, C. Y.、Yu, Y. W. Y.、Chen, T. J.、Hong, C. J.(2003)。Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology and antidepressant response。American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics，123b，19-22。
76.	Heils, A.、Teufel, A.、Petri, S.(1996)。Allelic Variation of Human Serotonin Transporter Gene Expression。Journal of Neurochemistry，66，2621-2624。

圖書
1.	Robins, L. N.、Regier, D. A.(1991)。Psychiatric Disorders in America: The Epidemiologic Catchment Area Study。New York：Free Press。
2.	King, M.(2009)。Serotonin: The Medical Biochemistry Page。Indiapolis：Indiana University School of Medicine。

圖書論文
1.	Hatotani, N.、Nomura, J.、Kitayama, I.(1984)。Changes of brain monoamines in the animal model for depression。Psychoneuroendocrine Dysfunction。Berlin：Springer-Verlag。
2.	Hatotani, N.、Nomura, J.、Kitayama, I.(1981)。Neuroendocrine studies on the pathogenesis of depression。Neuroendocrine Regulation and Altered Behaviour。Berlin：Springer-Verlag。

推文
推薦
引用網址
引用嵌入語法
轉寄

top

:::

相關期刊
相關論文
相關專書
相關著作
熱門點閱

1.	Psychiatric Practice in the Era of Precision Medicine

無相關博士論文

無相關書籍

無相關著作

1.	Drug Augmentation for Treatment-refractory Major Depressive Disorder
2.	Predictive Effect of Life Events on Adolescent Depression in Taiwan
3.	Risk Factors of Sexual Dysfunction in Depressive Patients: A Cross-sectional Observational Multi-center Survey Using ASEX-CV in Taiwan
4.	Quetiapine-associated Facial Acneiform Eruptions: A Case Report
5.	Successful Electroconvulsive Therapy for a Severe and Recurrent Depressive Patient with Pulmonary Embolism: A Case Report
6.	Craving Is Related to Persisting Heroin Use among Patients in Methadone Maintenance Treatment
7.	A Survey on Sexual Assault Victims' Assessment and Treatment in Taiwan
8.	Prevalence of Antipsychotic Drugs Related to Constipation in Patients with Schizophrenia
9.	Benefits of Writing a Happy Diary
10.	The Association between Comorbid Psychiatric Symptoms and Remission of Internet Gaming Disorder among College Students and Non-student Adults
11.	Incidence and Risk Factors of Self-harm among Patients with Schizophrenia in Taiwan: A 12-year Retrospective Cohort Study
12.	Outcomes and Associated Factors of Children with Developmental Delay in an Early Intervention Program
13.	Sex Difference in Associations among Life Attitudes, Depression, and Suicidal Ideation: A Preliminary Study
14.	The Association between Internet Addiction and Depression
15.	The Treatment with Aripiprazole for Tardive Dyskinesia in a Patient with Schizoaffective Disorder

QR Code

臺灣人文及社會科學引文索引資料庫系統

詳目顯示

臺灣人文及社會科學引文索引資料庫